In summary, we have described the FoxO1/Rictor axis as being involved in a BTK and PI3Kδ-independent mechanism inducing pAktS473 activity in CLL cells during BCR inhibitor therapy. Here, RICTOR is linked to B-cell chronic lymphocytic leukemia.